Drug Type Personalized antigen vaccine, Synthetic peptide vaccine |
Synonyms Neo Vax, Neoantigen vaccine, Neoantigen-based vaccine + [7] |
Target- |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chronic Lymphocytic Leukemia | Phase 1 | US | - | 17 Aug 2021 |
Ovarian Cancer | Phase 1 | US | 20 Nov 2020 | |
Renal Cell Carcinoma | Phase 1 | US | 03 Mar 2019 | |
Glioblastoma | Phase 1 | US | - | 11 Oct 2018 |
Metastatic melanoma | Phase 1 | US | 08 Oct 2018 | |
Metastatic Non-Squamous Non-Small Cell Lung Carcinoma | Phase 1 | US | 04 May 2018 | |
Bladder Cancer | Phase 1 | US | 01 Oct 2016 | |
Transitional Cell Carcinoma | Phase 1 | US | 01 Oct 2016 |
NCT03380871 (Pubmed) Manual | Phase 1 | Non-squamous non-small cell lung cancer First line | 38 | xblgcmzgmc(cmaaxfrbqk) = ifxrgsxoqz hjxdbuqglp (izdfyyccjm ) | Positive | 17 Aug 2022 | |
Phase 1 | Squamous non-small cell lung cancer First line | 38 | jcmcqybbdv(rabfgfixwx) = kbgjokeiir atdvmtwzyu (mactxnsbzt, 5.6 - 16.8) View more | Positive | 01 Jul 2021 | ||
jcmcqybbdv(rabfgfixwx) = kwsaskxmqu atdvmtwzyu (mactxnsbzt, 5.6 - 16.8) View more | |||||||
NCT02287428 (ASCO2018) Manual | Phase 1 | 10 | dexamethasone+NeoVax | pqooaqkahe(sozcwusrrf) = hsgolenloe ibrapevoda (kdkzhxxrji, 6.2 - 9.7) View more | Positive | 02 Jun 2018 |